ACAMPROSATE CA 333MG TAB NATIONAL CMOP
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the NATIONAL CMOP OFFICE (36C770), has issued RFQ 36C77026Q0092 for the procurement of ACAMPROSATE CA 333MG TAB pharmaceuticals. This opportunity is for Full and Open Competition. Quotations are due March 4, 2026, at 4:00 PM CST.
Scope of Work
This Request for Quotation (RFQ) seeks ACAMPROSATE CA 333MG EC TAB 180CT for delivery to multiple VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities, including Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Charleston. Deliveries will be staggered monthly over a three-month period, with the first delivery required 10 days After Receipt of Order (ARO).
Key Requirements
Products must meet specific technical and compliance standards:
- Labeling: Bar code labeling at the unit-of-use package level, conforming to GS1-128 or HIBCC standards.
- Equivalence: Therapeutic equivalence code of "A" by the FDA, unless all drugs in the family group are "B" rated.
- Expiration: Expiration dates must be no less than 12 months from the date of delivery.
- Packaging: Package sizes below 500 count require a Safety/Child Proof cap. Minimum bottle size is 100cc with a child safety cap, not exceeding 5.75 inches in circumference.
- Identification: Vendors must list National Drug Codes (NDCs) for each proposed product.
- Compliance: Drug Supply Chain Security Act (DSCSA) compliance documentation (Transaction History, Transaction Information, Transaction Statement) is required for prescription pharmaceuticals.
- Trade Agreements Act (TAA): TAA compliance is mandatory, and offerors must complete the 52.225-6 Trade Agreements Certificate. TAA compliant NDCs are preferred, though non-TAA compliant NDCs may be considered if no TAA product is available.
Submission Requirements
Offerors must submit a complete quotation package via email to sarah.fry2@va.gov by the deadline. Required documents include:
- Signed SF1449 (Solicitation cover page).
- Completed Excel pricing schedule (S02_Pricing Schedule_Q0092.xlsx), including the place of manufacture for all line items. Vendors must complete all areas highlighted in orange.
- Valid and unexpired State Wholesale Distributor License.
- Completed Trade Agreement Act (TAA) Certificate (52.225-6), including the place of manufacturing.
- Vendors must be registered and current in SAM.gov.
Contract & Timeline
- Solicitation Number: 36C77026Q0092
- Contract Type: Request for Quotation (RFQ)
- Set-Aside: Full and Open Competition
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a 1300-employee size standard.
- Product Service Code: 6505 (Drugs And Biologicals)
- Response Due: March 4, 2026, at 4:00 PM CST
- Published: February 25, 2026
Evaluation Criteria
Quotes will be evaluated based on Technical, Past Performance, Delivery, and Price. The government reserves the right to consider quotations other than the lowest price if they offer additional benefit. Offers must meet minimum requirements to be considered compliant. Offerors agree to hold prices firm for 30 calendar days.
Additional Notes
Only one quote per vendor is allowed. If proposing an NDC different from the listed one, quantities must be adjusted and noted in "Vendor Comments." Expiration dates for pharmaceuticals must be at least one year from the date of delivery; provide expiration dates in "Vendor Comments" if short-dated. Tracking information for shipments must be emailed to cynthia.triebel@va.gov.